Case Report
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Radiol. Oct 28, 2024; 16(10): 616-620
Published online Oct 28, 2024. doi: 10.4329/wjr.v16.i10.616
Cryoablation for intrapulmonary bronchial cyst: A case report
Zhong-Hai Li, Yang-Yang Ma, Li-Zhi Niu, Ke-Cheng Xu
Zhong-Hai Li, Department of Radiology, Guangzhou Fuda Cancer Hospital, Guangzhou 510665, Guangdong Province, China
Yang-Yang Ma, Central Laboratory, Guangzhou Fuda Cancer Hospital, Guangzhou 510665, Guangdong Province, China
Li-Zhi Niu, Ke-Cheng Xu, Department of Oncology, Guangzhou Fuda Cancer Hospital, Guangzhou 510665, Guangdong Province, China
Co-first authors: Zhong-Hai Li and Yang-Yang Ma.
Co-corresponding authors: Li-Zhi Niu and Ke-Cheng Xu.
Author contributions: Li ZH acquired clinical data; Ma YY wrote the paper; Li ZH was responsible for collecting clinical data; Ma YY proposed, designed and performed patient follow up; all the authors have read and approved the final manuscript. Both authors have made crucial and indispensable contributions towards the completion of the project and thus qualified as the co-first authors of the paper. Both Niu LZ and Xu KC have played important and indispensable roles in the innovation of case reporting, data interpretation and manuscript preparation as the co-corresponding authors. Niu LZ conceptualized, designed, and supervised the whole process of the project. He revised and submitted the early version of the manuscript. Xu KC was responsible for data re-analysis and re-interpretation, comprehensive literature search. This collaboration between Niu LZ and Xu KC is crucial for the publication of this manuscript and other manuscripts still in preparation.
Informed consent statement: Written informed consent was obtained from the patient for publication of this report and any accompanying images.
Conflict-of-interest statement: All authors declare that they have no conflict of interest.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Li-Zhi Niu, MAMS, MD, PhD, Attending Doctor, Chief Physician, Department of Oncology, Guangzhou Fuda Cancer Hospital, No. 2 Tangde West Road, Tianhe District, Guangzhou 510665, Guangdong Province, China. niuboshi@fudahospital.com
Received: July 5, 2024
Revised: September 10, 2024
Accepted: September 20, 2024
Published online: October 28, 2024
Processing time: 114 Days and 23.5 Hours
Abstract
BACKGROUND

Bronchial cysts are congenital malformations usually located in the mediastinum, and intrapulmonary localization is very rare. Cryoablation is a novel therapeutic approach that promotes tumor necrosis and stimulates anti-tumor immune responses.

CASE SUMMARY

This article reports a case of a 68-year-old male patient who was diagnosed with an intrapulmonary bronchogenic cyst by computed tomography examination and pathology, and the patient subsequently underwent cryoablation therapy and achieved complete response with after 3 months of follow-up.

CONCLUSION

Intrapulmonary bronchogenic cysts are very rare, cryoablation therapy is feasible, safe, and effective for intrapulmonary bronchial cysts.

Keywords: Intrapulmonary bronchial cyst; Cryoablation; Complete response; Case report

Core Tip: Cryoablation, effective for intrapulmonary bronchogenic cysts, offers a safe therapeutic option. A 68-year-old male achieved complete response post-treatment, highlighting its feasibility and efficacy in managing these rare cysts.